[State of immunological reactivity in breast cancer patients receiving prednisolone treatment].
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D006801:Humans; D006914:Hydroxysteroids / Q000652:urine; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D007958:Leukocyte Count; D008213:Lymphocyte Activation / Q000187:drug effects; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage*; D012882:Skin Tests; D013997:Time Factors
D015068:17-Ketosteroids; D006914:Hydroxysteroids; D011239:Prednisolone
Sostoianie immunologicheskoĭ reaktivnosti u bol'nykh rakom molochnoĭ zhelezy, poluchaiushchikh lechenie prednizolonom.